MedPath

多多药业有限公司

Ownership
-
Established
1999-12-15
Employees
-
Market Cap
-
Website
http://www.hljdd.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

144

NMPA:144

Drug Approvals

Diammonium Glycyrrhizinate Injection

Product Name
甘草酸二铵注射液
Approval Number
国药准字H20094213
Approval Date
Aug 3, 2024
NMPA

Clindamycin Phosphate Vaginal Gel

Product Name
克林霉素磷酸酯阴道凝胶
Approval Number
国药准字H20090261
Approval Date
Feb 14, 2024
NMPA

Protamine Sulfate Injection

Product Name
硫酸鱼精蛋白注射液
Approval Number
国药准字H23021620
Approval Date
Jan 14, 2024
NMPA

Citicoline Sodium Injection

Product Name
胞磷胆碱钠注射液
Approval Number
国药准字H19993355
Approval Date
Jan 14, 2024
NMPA

Citicoline Sodium Injection

Product Name
胞磷胆碱钠注射液
Approval Number
国药准字H19993356
Approval Date
Jan 14, 2024
NMPA

Procaine Hydrochloride Injection

Product Name
盐酸普鲁卡因注射液
Approval Number
国药准字H23021387
Approval Date
Jan 14, 2024
NMPA

Chloramphenicol Injection

Product Name
氯霉素注射液
Approval Number
国药准字H23020271
Approval Date
Jan 14, 2024
NMPA

Hydrocortisone Injection

Product Name
氢化可的松注射液
Approval Number
国药准字H23020273
Approval Date
Jan 14, 2024
NMPA

Gentamicin Sulfate Injection

Product Name
硫酸庆大霉素注射液
Approval Number
国药准字H23020269
Approval Date
Jan 14, 2024
NMPA

Verapamil Hydrochloride Injection

Product Name
盐酸维拉帕米注射液
Approval Number
国药准字H23020293
Approval Date
Jan 14, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 15
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.